AURA Competitors & Alternatives
Compare Aura Biosciences Inc with similar stocks in the same industry
Biotechnology
AURA
Main Stock$7.21
+1.41%
Tradestie Score
31
Market Cap
$382.04M
Analyst Upside
+130.2%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Ocular Oncology Therapeutics
Major Customers
2
Future oncology clinics
Academic medical centers
Critical Suppliers
2
CROs for clinical trials
Biomanufacturing partners
Direct Ecosystem Rivals
1
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$9.76
-2.01%
|
$791.82M | - | 35 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$7.15
-5.42%
|
$757.72M | - | 33 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$11.86
-8.84%
|
$748.90M | - | 45 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$15.01
-3.04%
|
$718.62M | 6.4 | 52 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$19.77
-1.27%
|
$715.25M | - | 31 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
+0.19%
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$145.03
-4.89%
|
$699.30M | - | 49 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
+0.04%
|
$683.46M | - | 49 | Compare |
|
ANL
ANL
|
$9.97
-6.03%
|
$677.47M | - | 48 | Compare |
More AURA Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
215 stocks in this industry